Prior to submitting your manuscript, please ensure that it has been prepared according to the guidelines below.
 

INTRODUCTION

  Aims & Scope

This journal aims to publish high quality articles in the modern disciplines and sub-disciplines of biology, life sciences and medicine, and recognizes the interdisciplinary nature of biological and medical sciences, considers research articles, review articles, case reports and short communications, with a focus on cellular and molecular biology, gene therapy, genetics, microbiology, cancer research, disease research (humans and animals), and other related areas.
If your manuscript is dealing with one of the above mentioned topics you are always welcome to submit your manuscript for publication in our journal Advances in Biology and Medicine.

  Submission method

Please send the complete manuscript with tables and figures as an e-mail attachment to the e-mail address: editor@advbiomed.org.
 

BEFORE YOU BEGIN

  Ethics in publishing

The work described in your article must have been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans http://www.healthscience.net/resources/declaration-of-helsinki/; EC Directive 86/609/EEC for animal experiments (http: // ec. europa. eu /environment/chemicals/lab animals/legislation en. htm); This must be stated at an appropriate point in the article.

  Conflict of interest

It is the policy of Advances in biology and medicine Publications to adhere in principle to the Conflict of Interest policy recommended by the International Committee of Medical Journal Editors (ICMJE, http:// www. icmje. org/index. html #conflict ). The authors must declare conflicts of interest (Declaration of Interests). In specific, we request for the following: 1) all relevant potential conflicts of interest for each named author and/or a statement of no-conflicts if there are none relevant to the contents of the article for any author(s), 2) disclosure of how the article is funded, and in specific, the disclosure of any and all pharmaceutical company funding (partial or total) or a statement that there was no involvement of a pharmaceutical/other company (if this is the case) and 3) comprehensive explanation of the role of the sponsors in article preparation (if the article is sponsored in part or whole).

  Authorship

All authors should have made substantial contributions to all of the following: 1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, 2) drafting the article or revising it critically for important intellectual content, 3) final approval of the version to be submitted. Authors are expected to consider carefully the list and order of authors before submission. Any addition, deletion or rearrangement of author names in the authorship list is generally not allowed. Only in exceptional circumstances will the Editor consider the change of authors after the manuscript has been accepted. To request such a change, the Editor must receive the following from the corresponding author: 1) the reason for the change in author list and 2) written confirmation through e-mail from all authors that they agree with the addition, removal or rearrangement.
 

PREPARATION

  General style

Please submit your paper in Word Document format. The test of the manuscript should be in single-column format without page numbers. Please do not include any line numbers or running headers or footers. Please remove any “hidden edits” from your paper prior to submission by using track changes then accept changes. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the wordprocessor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. Do not embed "graphically designed" equations or tables, but prepare these using the wordprocessor's facility. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns.  Do not import the figures into the text file but, instead, indicate their approximate locations directly in the electronic text and on the manuscript. To avoid unnecessary errors you are strongly advised to use the “spell-check” and “grammar-check” functions of your wordprocessor.

  Cover letter

A cover letter must be included with each manuscript submission. It should be concise and explain why the content of your paper is significant, placing your findings in the context of existing work and why it fits the scope of the journal. Please confirm that neither the manuscript nor any parts of its content are currently under consideration or published in another journal. Any prior submissions of the manuscript to our journals must be acknowledged.

  Paper layout

1.  Original Paper
Abstract (150-300 words)
Introduction
Materials and methods
Results
Discussion
Conclusion【optional】
Acknowledgements【optional】
References
2.  Review
Summary (150-300 words)
Introduction
Ordered process according to authors style
Discussion
Conclusion【optional】
Acknowledgements【optional】
References
3.  Case report
Summary
Case presentation
Discussion
Conclusion【optional】

  Manuscript

Use Times New Roman, font size 12, and spacing 1.5. Alignment Justified. Use a single tab on the first line of each new paragraph. Do not use page breaks or multiple returns between sections. Sub-titles and general headings should be presented in lower case letters. Use British English or American English spellings throughout your manuscript, but not both. Please prepare the manuscript strictly in the following order:
1.  Title page
1)  The title of the article. Use sentence case.
2)  Running title (maximum 100 characters with spaces)
3)  Full names and full postal addresses, and e-mail addresses of the corresponding author(s).
4)  Indicate affiliations of the authors by number (not symbols).
5)  Indicate equal contribution by #.
6)  Indicate the corresponding author(s) by *.
7)  Key words (3-10). Avoid general and plural terms and multiple concepts.
2.  Abstract/Summary
The section should be continuous (not structured) and without reference numbers. Abbreviations that appear once only, should be defined in full, unless a gene name. If abbreviations appear more than once, the definition should be provided once, and then subsequently used throughout the Abstract.
3.  Introduction
The introduction should give brief background information and state the reasons and purposes behind the study.
4.  Materials and methods
This section should include sufficient technical information to allow the experiments to be repeated. Methods already published should be indicated by a reference: only relevant modifications should be described. Describe your selection of observational or experimental subjects (patients or animals, including controls and the number in each study group) clearly. Identify the methods, apparatus, equipment, reagents, and procedures used. An outline of the statistical methods should be included here.
5.  Result
In this section, the finding of the works should be presented. Use tables and figures appropriately to improve the clarity of the presentation.
6.  Discussion
This section should explore the significance of the results of the work. Discuss the results in relation to other published works in the same field, but do not over-citing literatures. Offer explanations for any differences between the presented work and previous studies. Identify hypotheses and speculation clearly.
7.  References
1)  Please ensure that every reference cited in the text is also present in the reference list and vice versa. Unpublished results and personal communications are not recommended in the reference list. Citation of a reference as “in press” implies that the item has been accepted for publication.
2)  References must be numbered consecutively in the order mentioned, with Arabic numerals in brackets e.g., (1,2)(3-5). References first cited in a table or figure legend should be numbered so that they will be in sequence with references cited in the text at the point where the table or figure is first mentioned.
3)  Non-English references should not be included in the reference list unless English Abstracts for these references are available.
4)  List all the authors when there are three or fewer; when there are four or more, list the first three, and followed by “et al”.
5)  Journal names should be abbreviated according to the List of Title Word Abbreviations (http://www.issn.org/services/online-services/access-to-the-ltwa/)
6)  Following are examples of order and style, which should be strictly adhered to:
Reference to a journal publication:
1. Hutchinson JP, Fogarty AW, Hubbard R, et al: Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J 46:795-806, 2015.
2. Li Y: Tiopronin tablets joint metformin treatment curative effect observation of nonalcoholic fatty liver disease. Mod Med Health Care 25: 2000-2001, 2009. [In Chinese]
3. Scadden DT, Schenkein DP, Bernstein Z, et al: Combined immunotoxin and chemotherapy for AIDS-related non-Hodgkin’s lymphoma. Cancer (in press).
Reference to a book:
4. Strunk W. Jr, White EB: The elements of style, fourth ed, Longman, New York, 2000.
5. Mettam GR, Adams LB: How to prepare an electronic version of your article. In: Introduction to the Electronic Age. Jones BS, Smith RZ (eds). E-Publishing Inc., New York, pp281-304, 2009.
Reference to a website:
6. World Health Organization, Global hepatitis report 2017. http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1, 2017 (accessed 2017.05.09)
8.  Figures
1)  Submission of figures implies that the images or parts thereof have not been published elsewhere (unless mentioned and/or cited in the text and permission has been obtained and provided to us).
2)  Images showing any patient or patient’s scans should not contain information that might identify them, unless you provide written permission from the patient allowing use of the specific image.
3)  Acceptable file format: TIFF or JPEG, keep to a minimum resolution of 300 dpi.
4)  Acceptable color mode: RGB will offer the best reproduction of your data; CMYK is also acceptable; gray scale mode is also acceptable for black and white figures and line art.
5)  Create your figures at the following size: 8.00 cm (3.15 in) wide for a single-column figure; 17.00 cm (6.70 in) maximum for a double-column figure; maximum height 20.00 cm (7.87 in).
6)  Labels must be sized in proportion to the image, sharp, and clearly legible. Figure sections may be divided and subdivided as follows: A, B, C; A a, b, c; A a-1, a-2.
7)  Figure backgrounds must be white. White space surrounding figures should be cropped so that the image is as close to the edges of the page as possible.
9.  Figure legends
Figure legends should be listed one after the other, as part of the text document and separate from the figure files. Figure legends must begin with a brief title for the whole figure and continue with a short description of each panel or part. All symbols (eg. asterisks, hashtags) used to indicate significant differences in the figures must be defined accordingly in the figure legend. All error bars must be defined in the figure legend. Legends should not contain any details of the methods.
10.  Tables
1)  Each table should be submitted on separate page.
2)  Times New Roman. Font size 12. Spacing 1.5.
3)  Label using Roman numerals: Table I, Table II.
4)  Include a short title.
5)  All symbols and abbreviations should be defined immediately below the table.
 

AFTER ACCEPTANCE

  Proof

Authors must check their manuscript carefully before submission, after responding to peer-review, and when answering queries raised at the proof stage. Any errors will be faithfully transferred into the final PDF and print versions.

  Copyright

Submission of a manuscript implies that the work described has not been published before (except in the form of an abstract or as part of a published lecture, or thesis) and that it is not under consideration for publication elsewhere. All works published by us are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited.